CORPORATE OVERVIEW

ScarX Therapeutics (ScarX) is a biotechnology company that discovers and develops innovative treatments for dermal scarring (fibrosis). ScarX’s lead candidate, SCX-001, will be the first prescription cream for the reduction of post-surgical scarring.

SCX-001 is a topical cream that reduces the occurrence of scars following surgery. Nefopam, the active drug substance in SCX-001 is a well characterized small molecule that inhibits the protein that signals scar formation. 
+ More

ScarX's dermal scarring therapeutic seeks to address the unmet need of the 100+ million people in developed countries worldwide who experience post-surgical scarring
+ More

about scarring

Scarring is a natural part of the wound healing process. Scar type and severity are determined by a number of different factors.

+ More

latest news

ScarX's latest news is available via MaRS Innovation.

+ More